Chemotherapy

Port Malfunction Caused by Initial Placement

Published in Women's Health Weekly, March 11th, 2000

Scientists presented findings at the Society of Gynecologic Oncologists 31st Annual Meeting showing that initial placement of a subcutaneous implanted central venous port (SIP) catheter tip in the central venous system will prevent future malfunction.

Two hundred and thirty six patients with SIP placement were studied from 1993 until 1998. Researchers examined medical histories, operative reports, chest radiographs, and catheter tip placement.

"Patients were followed until SIP removal, death, or the most recent documentation of SIP function," David E. Cohn reported in a conference presentation entitled "Factors Predicting Subcutaneous Implanted...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry